RSWM evidence report
Evidence date: 2026-10-01. Research observations only.
What can I do with this stock?
Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.
Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.
Today: intraday
Evidence unavailable
No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
- No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
Next week: five trading sessions
No qualifying opportunity
No candidate with a primary five-session horizon in the coherent source run.
- No candidate with a primary five-session horizon in the coherent source run.
Long term: one to three years
Research only
A financial screen alone does not establish an investment recommendation.
- A current, source-backed thesis and valuation review is required.
Investment evidence
- Statement coverage
- FULL_STATEMENTS
- Financial source retrieved
- 2026-09-29T23:41:30.806601+00:00
Metrics
- latest_annual_period
- 2026-03-31
- revenue
- 45541300000.0
- net_income
- 520100000.0
- operating_cash_flow
- 3167400000.0
- free_cash_flow
- 1332500000.0
- total_assets
- 36172200000.0
- total_liabilities
- 22561700000.0
- total_equity
- 13610500000.0
- cash
- 53585000.0
- total_debt
- 16876400000.0
- revenue_growth
- -0.05630119585646409
- earnings_growth
- -2.29960019990005
- net_margin
- 0.011420403018798321
- roe
- 0.03821314426362
- debt_to_equity
- 1.2399544469343522
- cash_conversion
- 6.089982695635455
- free_cash_flow_margin
- 0.029259155974906293
- trailing_pe
- 36.54
- forward_pe
- Not supplied
- peg_ratio
- Not supplied
- price_to_book
- Not supplied
- dividend_yield
- Not supplied
Other positional research
No qualifying opportunity
No candidate at another positional horizon in the coherent source run.
- No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
- Decision ID
- decision-41f1d628725509b793e9622be53165069813317c1f2d98bf8ffc6b90c330bd3f
- Policy
- stock-decisions-v1
- Evidence bundle hash
- 9a63bdb87524b44d86e2e50c596c9c8e16a9cb08581db03bfd7c71cac92f5688
- market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
- validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
- financial-statements: 1fb3e8f78ace8c6e38b41f5051d935f830cfe72a883c268e42d11abcec28b8d9
- daily-price: 6bf5bd5b9482f8484307caca8ad15133d20226d97609577f634eec948f2bf75e
- Conditional research decisions are not orders or personalized position sizes.
- Scenario payoffs are assumptions, not probabilities or expected returns.
- A stop price does not guarantee a maximum loss through a gap or illiquidity.
Download the decision evidence as JSON
Numerical report available. Evidence briefing is queued or awaiting retry.
Cached observations and evidence limits
- Price source verification: REPAIRED.
- The cached closing price on 2026-10-01 was INR 202.21.
- The trailing 5-session price return was -8.30%.
- The trailing 20-session price return was -2.29%.
- The trailing 60-session price return was 6.66%.
- The trailing 250-session price return was 30.94%.
- Average cached traded value over twenty sessions was INR 16,322,995.
- The closing price was -14.05% below its highest close in the available trailing year.
- Fundamental coverage is FULL_STATEMENTS; retrieved 2026-09-29T23:41:30.806601+00:00 from EODHD.
- The cached financial metric latest annual period is 2026-03-31.
- The cached financial metric revenue growth is -0.05630119585646409.
- The cached financial metric net margin is 0.011420403018798321.
- The cached financial metric roe is 0.03821314426362.
- The cached financial metric debt to equity is 1.2399544469343522.
- The cached financial metric cash conversion is 6.089982695635455.
- The cached financial metric free cash flow margin is 0.029259155974906293.
- Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.